Dear All,
My name is Lucia and I write to you from Italy (so sorry for my english).
My mother is affected by adenocarcinoma in first hypothesis of Bilo-pancreatic origin (biopsy result) and today has begun here first cycle of GemCIS (she is not operable)
After reading this discussion I contacted Merk’s reference persons in Italy and in UK to received some information on MK 3475 clinical trial in Europe (https://clinicaltrials.gov/ct2/show/stu … ocs=Y#locn) .
They told me there is no Clinical Trials recruiting in US or in europe but It seems to me from this discussion and other I founded in cholang Foundation forum that this is not true.
I’m a little confused.
In any case my mother subscribed a clinical trial for a target therapy released by Niguarda Milan Oncology team. In this days they are analising my mother biopsy results to verify if they are positive to ALK ROS1 or TRKa to start a DXDX 101 (now entrectinib) therapy.
Everyday is a new day
Thanks a lot
Lucia